Test Price
2,800 AED✅ Home Collection Available
WNT1 Gene Osteogenesis Imperfecta Type XV Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This advanced Next-Generation Sequencing (NGS) test analyzes the WNT1 gene to detect pathogenic variants causing Osteogenesis Imperfecta Type XV, a rare genetic disorder characterized by fragile bones, recurrent fractures, and potential extraskeletal features. Our targeted NGS panel includes full gene coverage with Sanger confirmation for all clinically relevant variants.
| Feature | Our Test (ISO 9001:2015 Certified Lab) | Closest Alternative (Standard Hospital Lab) |
|---|---|---|
| Precision | >99.9% Sensitivity & Specificity for WNT1 variants | Variable; may rely on less comprehensive panels |
| Methodology | Targeted NGS with Sanger confirmation | Often targeted mutation analysis only |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Accreditation | ISO 9001:2015, DHA-Compliant | Varies |
| Home Collection | Yes (VIP, cold-chain, 8 AM – 11 PM) | Limited |
Physician Insight & Safety Protocols
Note from Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA ID: 9294403): “Interpretation of WNT1 variants must be contextualized within the patient’s full clinical phenotype including fracture history, bone density, and family pedigree. A positive finding alone does not confirm disease severity; multidisciplinary care — involving orthopedics, endocrinology, and physiotherapy — is essential for optimizing bone health and preventing fractures. I recommend confirmatory testing of parental samples to assess inheritance pattern.”
Medication Advisory
Do not discontinue prescribed medication without consulting your doctor. Abrupt cessation of bisphosphonates, calcium, or vitamin D supplements could worsen bone fragility. Always follow your treating physician’s guidance regarding medication adjustments.
Safety Exclusion Criteria & Emergency Red Flags
- This test is not available for individuals under 18 without appropriate legal guardian consent as per Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Inform the lab if you have had a recent blood transfusion or stem cell transplant to prevent sample contamination.
- Emergency Red Flags: Seek immediate medical attention if you experience sudden severe bone pain, inability to move a limb, or new deformities. Do not wait for test results.
Patient FAQ & Clinical Guidance
1. How accurate is this test for diagnosing Osteogenesis Imperfecta Type XV?
Our targeted NGS achieves diagnostic sensitivity and specificity exceeding 99.9% for WNT1 pathogenic variants when interpreted by a board-certified molecular geneticist.
2. What sample types are accepted?
We accept peripheral whole blood (3–5 ml in EDTA tube) or a blood spot on an FTA card for less invasive collection. Saliva samples are not currently validated for this test.
3. How long do results take and is genetic counseling included?
Results are available in 3–4 weeks. The package includes a pre-test genetic counseling session to map the family pedigree and a post-test consultation to discuss implications.
UAE Regulatory & Data Privacy Adherence
This service strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted, stored securely, and accessible only to authorized healthcare professionals. Laboratory accredited under ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139). For insurance verification or home collection, contact +971 54 548 8731 (WhatsApp).
Clinical & Logistical Metadata
| Test Name | WNT1 Gene Osteogenesis Imperfecta Type XV Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA) or Blood Spot (FTA Card) |
| Methodology Used | Targeted Next-Generation Sequencing (NGS) with Sanger Confirmation |
| ICD-10-CM Code | Q78.0 (Osteogenesis Imperfecta) |
| LOINC Code | 81723-5 (WNT1 gene targeted mutation analysis) |
| DHA Facility License & Laboratory Address | License No. 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians